Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Conference News THT 2025

Positive Results With Carillon Mitral Device Seen in Real-world Registries

Todd Neale

February 21, 2025

News Daily News

US and European Valvular Guidelines Mostly Concordant, Analysis Finds

L.A. McKeown

August 21, 2023

News Daily News

Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes

Yael L. Maxwell

December 06, 2022

News Conference News PCR London Valves 2021

MitraClip Cuts HF Hospitalizations in Real-World Registry: EXPAND

Shelley Wood

November 26, 2021

News Daily News

EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management

L.A. McKeown

September 22, 2021

News Daily News

Echo Features Pinpoint Those Unlikely to Benefit From MitraClip

Shelley Wood

December 15, 2020

News Daily News

Transcatheter Tricuspid, Mitral Repair Appear Safe to Combine: Registry Data

Caitlin E. Cox

January 20, 2020

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

Shelley Wood

September 23, 2018

News Industry News

4C Medical Exceeds $8 Million Convertible Note Financing Round Led by Anges Québec

July 20, 2017

News Industry News

4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum

June 16, 2017

Presentation TVT 2014

Impact of Pulmonary Hypertension, RV Dysfunction, and/or Severe Tricuspid Regurgitation on Mitral Valve Therapies

Presenter: E. Murat Tuzcu

June 05, 2014

News Daily News

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

L.A. McKeown

March 20, 2014

Presentation TCT 2013

When Does Pulmonary Hypertension, RV Dysfunction and/or Tricuspid Regurgitation Derail the Potential for Successful Mitral Valve Intervention?

Presenter: Michael Davidson

October 28, 2013

Advertisement

Positive Results With Carillon Mitral Device Seen in Real-world Registries

US and European Valvular Guidelines Mostly Concordant, Analysis Finds

Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes

MitraClip Cuts HF Hospitalizations in Real-World Registry: EXPAND

EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management

Echo Features Pinpoint Those Unlikely to Benefit From MitraClip

Transcatheter Tricuspid, Mitral Repair Appear Safe to Combine: Registry Data

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

4C Medical Exceeds $8 Million Convertible Note Financing Round Led by Anges Québec

4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum

Impact of Pulmonary Hypertension, RV Dysfunction, and/or Severe Tricuspid Regurgitation on Mitral Valve Therapies

New Valvular Heart Disease Guidelines Integrate Catheter-based Interventions

When Does Pulmonary Hypertension, RV Dysfunction and/or Tricuspid Regurgitation Derail the Potential for Successful Mitral Valve Intervention?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content